Role of gangliosides in tumour progression: A molecular target for cancer therapy?
- 1 February 1996
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 46 (2) , 140-144
- https://doi.org/10.1016/s0306-9877(96)90014-6
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Gangliosides and neurological diseases.BMJ, 1992
- Cell-Surface Ganglioside GD2 in the Immunohistochemical Detection and Differential Diagnosis of NeuroblastomaAmerican Journal of Clinical Pathology, 1991
- Ganglioside GM3:GD3 ratio as an index for the management of melanomaCancer, 1991
- Metabolism and intracellular transport of glycosphingolipidsBiochemistry, 1990
- Density-dependent expression of ganglioside GM3 by human skin fibroblasts in an all-or-none fashion, as a possible modulator of cell growth in vitroExperimental Cell Research, 1990
- Determination of Gangliosides in Six Human Primary MedulloblastomasJournal of Neurochemistry, 1990
- Shed tumor gangliosides and progression of human neuroblastomaBlood, 1990
- Glycosphingolipids of human myometrium and endometrium and their changes during the menstrual cycle, pregnancy and ageingReproduction, 1990
- Gangliosides in normal human serumEuropean Journal of Biochemistry, 1989
- Gene-Regulated Expression of Glycolipids: Appearance of GD3 Ganglioside in Rat Cells on Transfection with Transforming Gene E1 of Human Adenovirus Type 12 DNA and Its Transcriptional Subunits1The Journal of Biochemistry, 1984